CTI BioPharma Corp. EPS - Earnings per Share 2010-2023 | CTIC
CTI BioPharma Corp. eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| CTI BioPharma Corp. Annual EPS |
| 2022 |
$-0.81 |
| 2021 |
$-1.09 |
| 2020 |
$-0.74 |
| 2019 |
$-0.69 |
| 2018 |
$-0.52 |
| 2017 |
$-1.24 |
| 2016 |
$-1.86 |
| 2015 |
$-6.51 |
| 2014 |
$-6.46 |
| 2013 |
$-4.30 |
| 2012 |
$-19.80 |
| 2011 |
$-35.30 |
| 2010 |
$-64.70 |
| 2009 |
$-76.50 |
| CTI BioPharma Corp. Quarterly EPS |
| 2023-03-31 |
$-0.10 |
| 2022-12-31 |
$-0.10 |
| 2022-09-30 |
$-0.13 |
| 2022-06-30 |
$-0.21 |
| 2022-03-31 |
$-0.37 |
| 2021-12-31 |
$-0.39 |
| 2021-09-30 |
$-0.26 |
| 2021-06-30 |
$-0.21 |
| 2021-03-31 |
$-0.23 |
| 2020-12-31 |
$-0.20 |
| 2020-09-30 |
$-0.15 |
| 2020-06-30 |
$-0.19 |
| 2020-03-31 |
$-0.20 |
| 2019-12-31 |
$-0.14 |
| 2019-09-30 |
$-0.17 |
| 2019-06-30 |
$-0.19 |
| 2019-03-31 |
$-0.19 |
| 2018-12-31 |
$0.02 |
| 2018-09-30 |
$-0.26 |
| 2018-06-30 |
$-0.20 |
| 2018-03-31 |
$-0.08 |
| 2017-12-31 |
$-0.28 |
| 2017-09-30 |
$-0.28 |
| 2017-06-30 |
$0.03 |
| 2017-03-31 |
$-0.71 |
| 2016-12-31 |
$-0.23 |
| 2016-09-30 |
$-1.04 |
| 2016-06-30 |
$-0.71 |
| 2016-03-31 |
$0.12 |
| 2015-12-31 |
$-1.11 |
| 2015-09-30 |
$-1.90 |
| 2015-06-30 |
$-1.90 |
| 2015-03-31 |
$-1.60 |
| 2014-12-31 |
$-2.86 |
| 2014-09-30 |
$0.30 |
| 2014-06-30 |
$-1.90 |
| 2014-03-31 |
$-2.00 |
| 2013-12-31 |
$1.20 |
| 2013-09-30 |
$-2.00 |
| 2013-06-30 |
$-1.70 |
| 2013-03-31 |
$-1.80 |
| 2012-12-31 |
$2.10 |
| 2012-09-30 |
$-3.80 |
| 2012-06-30 |
$-13.80 |
| 2012-03-31 |
$-4.30 |
| 2011-12-31 |
$-2.80 |
| 2011-09-30 |
$-8.00 |
| 2011-06-30 |
$-7.00 |
| 2011-03-31 |
$-17.50 |
| 2010-12-31 |
$-13.20 |
| 2010-09-30 |
$-6.50 |
| 2010-06-30 |
$-24.00 |
| 2010-03-31 |
$-21.00 |
| 2009-12-31 |
$-16.51 |
| 2009-09-30 |
$-27.00 |
| 2009-06-30 |
$-18.00 |
| 2009-03-31 |
$-15.00 |
